Vice President/Senior Vice President Electrophysiology
Pulse Biosciences
Vice President/Senior Vice President Electrophysiology
Pulse Biosciences
Non-thermal nanosecond pulsed-field ablation platform
Pulse Biosciences (Nasdaq: PLSE): Join the Future of Bioelectric Medicine
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company’s proprietary CellFX® nsPFA™ (nanosecond Pulsed Field Ablation) technology delivers nanosecond pulses of electrical energy to non-thermally ablate cells while sparing adjacent noncellular tissue.
The Company is actively pursuing the development of its CellFX nsPFA technology for use in the surgical treatment of atrial fibrillation and percutaneously in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. Visit pulsebiosciences.com to learn more.
Why Join Us?
At Pulse Biosciences, we are driven by purpose and innovation.
What You Will Experience:
About the Role
The Vice President/Senior Vice President of Electrophysiology (EP) Catheter Manufacturing will lead the development, production transition, and global scale-up of a next-generation EP catheter manufacturing organization. This executive leader will be responsible for defining and executing the end-to-end manufacturing strategy, building a high-performing team, and ensuring successful commercialization through scalable, cost-effective, and reliable manufacturing operations. The ideal candidate brings deep expertise in cardiac catheter or EP device manufacturing, demonstrated success scaling production from launch to high-volume commercialization, and extensive experience managing contract manufacturers and manufacturing transfers across global regions.
To Make an Impact, You Will:
To Excel, You Will Bring:
Ready to Shape the Future of Healthcare?
Apply today to join Pulse Biosciences and help us redefine the boundaries of medicine with bioelectric innovation. To learn more about us, visit our website at www.pulsebiosciences.com.
We provide equal employment opportunities (EEO) to all persons regardless of race, age, color, gender, sexual orientation, national origin, physical or mental disability, religion, or any other characteristic protected by federal, state or local law. We will make reasonable accommodations for qualified individuals with disabilities.
PRINCIPALS ONLY; UNSOLICITED CANDIDATE SUBMISSIONS FROM RECRUITERS OR THIRD-PARTY AGENCIES WILL BE CONSIDERED FREE REFERRALS.
Non-thermal nanosecond pulsed-field ablation platform
Pulse Biosciences uses Nanosecond Pulsed-Field Ablation (nsPFA) to ablate diseased cells with ultra-short electrical pulses while preserving surrounding tissue. Its CellFX System includes percutaneous and surgical tools, such as a soft tissue ablation electrode, a cardiac clamp, and a 360° cardiac catheter for AFib and other procedures. The company differentiates itself by focusing on high-value surgical applications in cardiology and soft tissue, aiming for precise, non-thermal tissue removal with less collateral damage. Its goal is to make the CellFX System a standard of care in bioelectric medicine and to grow in specialty surgical markets.
Explore more opportunities at Pulse Biosciences